Schedule 13G ownership disclosure
AGILE THERAPEUTICS INC
Common Stock · CUSIP: 00847L308
Event date: 2024-08-06
- Filing-level shares
- 350,000.00
- Percent of class
- 5.1%
- Mastrangeli Doug
Shares: 350,000.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002034373-24-000001
- Form type
- SCHEDULE 13G
- Filer
- AGILE THERAPEUTICS INC
- CIK
- CIK 1261249
- Filed
- Aug 26, 2024
- Reporting period
- Aug 06, 2024
- Description
- Schedule 13G beneficial ownership